MMAI (hydrochloride)

MMAI (5-Methoxy-6-methyl-2-aminoindan) hydrochloride is a selective serotonin releaser that does not produce psychoactive or hallucinogenic effects in the context of drug discrimination in rats. MMAI hydrochloride induces a behavioral syndrome in rats, including hypokinesia with freezing, spinning, Straub tail, flat posture, and reduced sleep time[1].

Product Specifications

CAS Number

[132980-17-7]

Product Name Alternative

5-Methoxy-6-methyl-2-aminoindan (hydrochloride)

UNSPSC

12352005

Target

5-HT Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/mmai-hydrochloride.html

Smiles

NC1CC2=C(C=C(OC)C(C)=C2)C1.[H]Cl

Molecular Formula

C11H16ClNO

Molecular Weight

213.70

References & Citations

[1]Marona-Lewicka D, et al. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan. Eur J Pharmacol. 1994 Jun 2;258 (1-2) :1-13.